224 related articles for article (PubMed ID: 17663506)
1. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
[TBL] [Abstract][Full Text] [Related]
2. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of the KLF6 gene in colorectal cancers.
Cho YG; Choi BJ; Kim CJ; Song JW; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2006 Jun; 114(6):458-64. PubMed ID: 16856969
[TBL] [Abstract][Full Text] [Related]
4. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.
Reeves HL; Narla G; Ogunbiyi O; Haq AI; Katz A; Benzeno S; Hod E; Harpaz N; Goldberg S; Tal-Kremer S; Eng FJ; Arthur MJ; Martignetti JA; Friedman SL
Gastroenterology; 2004 Apr; 126(4):1090-103. PubMed ID: 15057748
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
[TBL] [Abstract][Full Text] [Related]
6. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
9. Role of KLF6 tumor suppressor gene mutations in the development of colorectal carcinoma in an Egyptian population.
Wahab AH; Kassem AM; Matter S; El Deen AF; Helmy AS; Ismaeil MM; Zakaria MS
Hepatogastroenterology; 2010; 57(104):1405-10. PubMed ID: 21443094
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
11. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
Lièvre A; Landi B; Côté JF; Veyrie N; Zucman-Rossi J; Berger A; Laurent-Puig P
Oncogene; 2005 Nov; 24(48):7253-6. PubMed ID: 16044160
[TBL] [Abstract][Full Text] [Related]
12. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
Wang S; Kang L; Chen X; Zhou H
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
[TBL] [Abstract][Full Text] [Related]
13. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
[TBL] [Abstract][Full Text] [Related]
14. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
17. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
18. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
Wang SP; Chen XP; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1258-61. PubMed ID: 15598377
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene.
Trucco LD; Andreoli V; Núñez NG; Maccioni M; Bocco JL
FASEB J; 2014 Dec; 28(12):5262-76. PubMed ID: 25212220
[TBL] [Abstract][Full Text] [Related]
20. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
